Skip to main content
. 2021 Jun 17;11:615296. doi: 10.3389/fonc.2021.615296

Figure 3.

Figure 3

The correlation of METTL14 and immune infiltrates in rectal cancers. (A) The immune infiltrate analysis in the TIMER data set. (B) The immune infiltrate analysis in the TISIDB data set. (C) The correlation of METTL14 and immunoinhibitors in the TISIDB data set. (D) The correlation of METTL14 and immunostimulators in the TISIDB data set. (E) The correlation of METTL14 and chemokines in the TISIDB data set. (F) The correlation of METTL14 and chemokine receptors in the TISIDB data set. (G) The correlation of METTL14 and MHCs in the TISIDB data set. (H) The relative expression level of METTL14 in different immune subtypes. (I) The relative expression level of METTL14 in different molecular subtypes. CIN, chromosomal instability; GS, genome stable; HM-SNV, hypermutated single nucleotide variants; HM-indel, hypermutated insertion-deletion.